Table of Content

1. Research Scope & Methodology
1.1. Study Objectives
1.2. Scope Of Study
1.3. Methodology
1.4. Assumptions & Limitations

2. Executive Summary
2.1. Market Size & Estimates
2.2. Market Overview

3. Market Dynamics
3.1. Market Definition
3.2. Key Drivers
3.2.1. Demand From Governments For Diagnosing Covid-19 Positive Patients
3.2.2. Rise In Demand For Non-Invasive Diagnosis
3.2.3. Growth In The Number Of Diseases
3.2.4. Funding For Research And Development
3.2.5. Technological Advancements In The Market
3.3. Key Restraints
3.3.1. High Capital Requirement
3.3.2. Lack Of High Complexity Testing Centers

4. Key Analytics
4.1. Key Investment Insights
4.2. Porter’S Five Force Analysis
4.2.1. Buyer Power
4.2.2. Supplier Power
4.2.3. Substitution
4.2.4. New Entrants
4.2.5. Industry Rivalry
4.3. Opportunity Matrix
4.4. Vendor Landscape
4.5. Regulatory Framework
4.5.1. United States
4.5.2. Europe
4.5.3. Asia-Pacific

5. Market By Technology
5.1. Polymerase Chain Reaction
5.1.1. Real Time Pcr
5.1.2. Digital Pcr
5.2. Isothermal Nucleic Acid Amplification Technology
5.3. Other

6. Market By Product
6.1. Assays
6.2. Instruments
6.3. Software

7. Market By Application
7.1. Infectious Disease
7.1.1. Respiratory
7.1.2. Hospital Acquired Infections
7.1.3. Sexually Transmitted Infections
7.1.4. Gastro Intestinal Infections
7.2. Oncology
7.3. Prenatal
7.4. Others

8. Market By End-User
8.1. Hospitals
8.2. Clinics
8.3. Diagnostics Centres
8.4. Others

9. Geographical Analysis
9.1. North America
9.1.1. United States
9.1.2. Canada
9.2. Europe
9.2.1. United Kingdom
9.2.2. Germany
9.2.3. France
9.2.4. Italy
9.2.5. Russia
9.2.6. Belgium
9.2.7. Poland
9.2.8. Rest Of Europe
9.3. Asia Pacific
9.3.1. China
9.3.2. Japan
9.3.3. India
9.3.4. South Korea
9.3.5. Indonesia
9.3.6. Thailand
9.3.7. Vietnam
9.3.8. Australia & New Zealand
9.3.9. Rest Of Asia Pacific
9.4. Rest Of World
9.4.1. Latin America
9.4.2. Middle East & Africa

10. Company Profiles
10.1. Abbott Laboratories
10.2. Abacus Diagnostica
10.3. Biom?rieux Sa
10.4. Biocartis Nv
10.5. Danaher Corporation
10.6. Diasorin Spa
10.7. Bio-Rad
10.8. F Hoffmann-La Roche Ag
10.9. Luminex Corporation
10.10. Hologic Inc
10.11. Mesa Biotech
10.12. Spartan Biosciences Inc
10.13. Quantumdx Group Ltd
10.14. Quidel Corporation
10.15. Qiagen Nv



List of Figures


List of Tables


Table 1: Market Snapshot - Molecular Point Of Care Diagnostics
Table 2: Emergency Use Authorisation For Diagnostics By Fda
Table 3: Global Molecular Point Of Care Diagnostics Market, By Technology, Historical Years, 2016-2019 (In $ Million)
Table 4: Global Molecular Point Of Care Diagnostics Market, By Technology, Forecast Years, 2019-2028 (In $ Million)
Table 5: Global Polymerase Chain Reaction Market, By Region, Historical Years, 2016-2019 (In $ Million)
Table 6: Global Polymerase Chain Reaction Market, By Region, Forecast Years, 2019-2028 (In $ Million)
Table 7: Global Molecular Point Of Care Diagnostics Market, By Pcr Technology, Historical Years, 2016-2019 (In $ Million)
Table 8: Global Molecular Point Of Care Diagnostics Market, By Pcr Technology, Forecast Years, 2019-2028 (In $ Million)
Table 9: Global Real Time Pcr Market, By Region, Historical Years, 2016-2019 (In $ Million)
Table 10: Global Real Time Pcr Market, By Region, Forecast Years, 2019-2028 (In $ Million)
Table 11: Global Digital Pcr Market, By Region, Historical Years, 2016-2019 (In $ Million)
Table 12: Global Digital Pcr Market, By Region, Forecast Years, 2019-2028 (In $ Million)
Table 13: Global Isothermal Nucleic Acid Amplification Technology Market, By Region, Historical Years, 2016-2019 (In $ Million)
Table 14: Global Isothermal Nucleic Acid Amplification Technology Market, By Region, Forecast Years, 2019-2028 (In $ Million)
Table 15: Global Other Market, By Region, Historical Years, 2016-2019 (In $ Million)
Table 16: Global Other Market, By Region, Forecast Years, 2019-2028 (In $ Million)
Table 17: Global Molecular Point Of Care Diagnostics Market, By Product, Historical Years, 2016-2019 (In $ Million)
Table 18: Global Molecular Point Of Care Diagnostics Market, By Product, Forecast Years, 2019-2028 (In $ Million)
Table 19: Global Assays Market, By Region, Historical Years, 2016-2019 (In $ Million)
Table 20: Global Assays Market, By Region, Forecast Years, 2019-2028 (In $ Million)
Table 21: Global Instruments Market, By Region, Historical Years, 2016-2019 (In $ Million)
Table 22: Global Instruments Market, By Region, Forecast Years, 2019-2028 (In $ Million)
Table 23: Global Software Market, By Region, Historical Years, 2016-2019 (In $ Million)
Table 24: Global Software Market, By Region, Forecast Years, 2019-2028 (In $ Million)
Table 25: Global Molecular Point Of Care Diagnostics Market, By Application, Historical Years, 2016-2019 (In $ Million)
Table 26: Global Molecular Point Of Care Diagnostics Market, By Application, Forecast Years, 2019-2028 (In $ Million)
Table 27: Global Infectious Disease Market, By Region, Historical Years, 2016-2019 (In $ Million)
Table 28: Global Infectious Disease Market, By Region, Forecast Years, 2019-2028 (In $ Million)
Table 29: Global Molecular Point Of Care Diagnostics Market, By Infectious Disease, Historical Years, 2016-2019 (In $ Million)
Table 30: Global Molecular Point Of Care Diagnostics Market, By Infectious Disease, Forecast Years, 2019-2028 (In $ Million)
Table 31: Global Respiratory Market, By Region, Historical Years, 2016-2019 (In $ Million)
Table 32: Global Respiratory Disease Market, By Region, Forecast Years, 2019-2028 (In $ Million)
Table 33: Global Hospital Acquired Infections Market, By Region, Historical Years, 2016-2019 (In $ Million)
Table 34: Global Hospital Acquired Infections Market, By Region, Forecast Years, 2019-2028 (In $ Million)
Table 35: Global Sexually Transmitted Infections Market, By Region, Historical Years, 2016-2019 (In $ Million)
Table 36: Global Sexually Transmitted Infections Market, By Region, Forecast Years, 2019-2028 (In $ Million)
Table 37: Global Gastro Intestinal Infections Market, By Region, Historical Years, 2016-2019 (In $ Million)
Table 38: Global Gastro Intestinal Infections Market, By Region, Forecast Years, 2019-2028 (In $ Million)
Table 39: Global Oncology Market, By Region, Historical Years, 2016-2019 (In $ Million)
Table 40: Global Oncology Market, By Region, Forecast Years, 2019-2028 (In $ Million)
Table 41: Global Prenatal Market, By Region, Historical Years, 2016-2019 (In $ Million)
Table 42: Global Prenatal Market, By Region, Forecast Years, 2019-2028 (In $ Million)
Table 43: Global Others Market, By Region, Historical Years, 2016-2019 (In $ Million)
Table 44: Global Others Market, By Region, Forecast Years, 2019-2028 (In $ Million)
Table 45: Global Molecular Point Of Care Diagnostics Market, By End-User, Historical Years, 2016-2019 (In $ Million)
Table 46: Global Molecular Point Of Care Diagnostics Market, By End-User, Forecast Years, 2019-2028 (In $ Million)
Table 47: Global Hospitals Market, By Region, Historical Years, 2016-2019 (In $ Million)
Table 48: Global Hospitals Market, By Region, Forecast Years, 2019-2028 (In $ Million)
Table 49: Global Clinics Market, By Region, Historical Years, 2016-2019 (In $ Million)
Table 50: Global Clinics Market, By Region, Forecast Years, 2019-2028 (In $ Million)
Table 51: Global Diagnostic Centres Market, By Region, Historical Years, 2016-2019 (In $ Million)
Table 52: Global Diagnostic Centres Market, By Region, Forecast Years, 2019-2028 (In $ Million)
Table 53: Global Others Market, By Region, Historical Years, 2016-2019 (In $ Million)
Table 54: Global Others Market, By Region, Forecast Years, 2019-2028 (In $ Million)
Table 55: Global Molecular Point Of Care Diagnostics Market, By Geography, Historical Years, 2016-2019 (In $ Million)
Table 56: Global Molecular Point Of Care Diagnostics Market, By Geography, Forecast Years, 2019-2028 (In $ Million)
Table 57: North America Molecular Point Of Care Diagnostics Market, By Country, Historical Years, 2016-2019 (In $ Million)
Table 58: North America Molecular Point Of Care Diagnostics Market, By Country, Forecast Years, 2019-2028 (In $ Million)
Table 59: Europe Molecular Point Of Care Diagnostics Market, By Country, Historical Years, 2016-2019 (In $ Million)
Table 60: Europe Molecular Point Of Care Diagnostics Market, By Country, Forecast Years, 2019-2028 (In $ Million)
Table 61: Asia Pacific Molecular Point Of Care Diagnostics Market, By Country, Historical Years, 2016-2019 (In $ Million)
Table 62: Asia Pacific Molecular Point Of Care Diagnostics Market, By Country, Forecast Years, 2019-2028 (In $ Million)
Table 63: Rest Of World Molecular Point Of Care Diagnostics Market, By Region, Historical Years, 2016-2019 (In $ Million)
Table 64: Rest Of World Molecular Point Of Care Diagnostics Market, By Region, Forecast Years, 2019-2028 (In $ Million)


List of Tables


TABLE 1: MARKET SNAPSHOT - MOLECULAR POINT OF CARE DIAGNOSTICS
TABLE 2: EMERGENCY USE AUTHORISATION FOR DIAGNOSTICS BY FDA
TABLE 3: GLOBAL MOLECULAR POINT OF CARE DIAGNOSTICS MARKET, BY TECHNOLOGY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 4: GLOBAL MOLECULAR POINT OF CARE DIAGNOSTICS MARKET, BY TECHNOLOGY, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 5: GLOBAL POLYMERASE CHAIN REACTION MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 6: GLOBAL POLYMERASE CHAIN REACTION MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 7: GLOBAL MOLECULAR POINT OF CARE DIAGNOSTICS MARKET, BY PCR TECHNOLOGY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 8: GLOBAL MOLECULAR POINT OF CARE DIAGNOSTICS MARKET, BY PCR TECHNOLOGY, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 9: GLOBAL REAL TIME PCR MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 10: GLOBAL REAL TIME PCR MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 11: GLOBAL DIGITAL PCR MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 12: GLOBAL DIGITAL PCR MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 13: GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 14: GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 15: GLOBAL OTHER MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 16: GLOBAL OTHER MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 17: GLOBAL MOLECULAR POINT OF CARE DIAGNOSTICS MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 18: GLOBAL MOLECULAR POINT OF CARE DIAGNOSTICS MARKET, BY PRODUCT, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 19: GLOBAL ASSAYS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 20: GLOBAL ASSAYS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 21: GLOBAL INSTRUMENTS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 22: GLOBAL INSTRUMENTS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 23: GLOBAL SOFTWARE MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 24: GLOBAL SOFTWARE MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 25: GLOBAL MOLECULAR POINT OF CARE DIAGNOSTICS MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 26: GLOBAL MOLECULAR POINT OF CARE DIAGNOSTICS MARKET, BY APPLICATION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 27: GLOBAL INFECTIOUS DISEASE MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 28: GLOBAL INFECTIOUS DISEASE MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 29: GLOBAL MOLECULAR POINT OF CARE DIAGNOSTICS MARKET, BY INFECTIOUS DISEASE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 30: GLOBAL MOLECULAR POINT OF CARE DIAGNOSTICS MARKET, BY INFECTIOUS DISEASE, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 31: GLOBAL RESPIRATORY MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 32: GLOBAL RESPIRATORY DISEASE MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 33: GLOBAL HOSPITAL ACQUIRED INFECTIONS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 34: GLOBAL HOSPITAL ACQUIRED INFECTIONS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 35: GLOBAL SEXUALLY TRANSMITTED INFECTIONS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 36: GLOBAL SEXUALLY TRANSMITTED INFECTIONS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 37: GLOBAL GASTRO INTESTINAL INFECTIONS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 38: GLOBAL GASTRO INTESTINAL INFECTIONS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 39: GLOBAL ONCOLOGY MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 40: GLOBAL ONCOLOGY MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 41: GLOBAL PRENATAL MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 42: GLOBAL PRENATAL MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 43: GLOBAL OTHERS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 44: GLOBAL OTHERS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 45: GLOBAL MOLECULAR POINT OF CARE DIAGNOSTICS MARKET, BY END-USER, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 46: GLOBAL MOLECULAR POINT OF CARE DIAGNOSTICS MARKET, BY END-USER, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 47: GLOBAL HOSPITALS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 48: GLOBAL HOSPITALS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 49: GLOBAL CLINICS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 50: GLOBAL CLINICS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 51: GLOBAL DIAGNOSTIC CENTRES MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 52: GLOBAL DIAGNOSTIC CENTRES MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 53: GLOBAL OTHERS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 54: GLOBAL OTHERS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 55: GLOBAL MOLECULAR POINT OF CARE DIAGNOSTICS MARKET, BY GEOGRAPHY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 56: GLOBAL MOLECULAR POINT OF CARE DIAGNOSTICS MARKET, BY GEOGRAPHY, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 57: NORTH AMERICA MOLECULAR POINT OF CARE DIAGNOSTICS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 58: NORTH AMERICA MOLECULAR POINT OF CARE DIAGNOSTICS MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 59: EUROPE MOLECULAR POINT OF CARE DIAGNOSTICS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 60: EUROPE MOLECULAR POINT OF CARE DIAGNOSTICS MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 61: ASIA PACIFIC MOLECULAR POINT OF CARE DIAGNOSTICS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 62: ASIA PACIFIC MOLECULAR POINT OF CARE DIAGNOSTICS MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 63: REST OF WORLD MOLECULAR POINT OF CARE DIAGNOSTICS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 64: REST OF WORLD MOLECULAR POINT OF CARE DIAGNOSTICS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)